Matrix Metalloproteinases and Their Inhibitors in Tumor Progressiona
- 1 September 1994
- journal article
- review article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 732 (1), 222-232
- https://doi.org/10.1111/j.1749-6632.1994.tb24738.x
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Tumor Cell Interactions with the Extracellular Matrix During Invasion and MetastasisAnnual Review of Cell Biology, 1993
- Enhanced expression of a tumor‐cell‐derived collagenase‐stimulatory factor in urothelial carcinoma: Its usefulness as a tumor marker for bladder cancersInternational Journal of Cancer, 1993
- The matrix‐degrading metalloproteinasesBioEssays, 1992
- Tissue inhibitor of metalloproteinase‐2 (TIMP‐2) has erythroid‐potentiating activityFEBS Letters, 1992
- Expression of collagenase‐related metalloproteinase genes in human lung or head and neck tumoursInternational Journal of Cancer, 1991
- Tissue inhibitor of metalloproteinases from human bone marrow stromal cell line KM 102 has erythroid‐potentiating activity, suggesting its possibly bifunctional role in the hematopoietic microenvironmentFEBS Letters, 1990
- Primary Rat Embryo Cells Transformed by One or Two Oncogenes Show Different Metastatic PotentialsScience, 1986
- Molecular characterization and expression of the gene encoding human erythroid-potentiating activityNature, 1985
- Metastatic potential correlates with enzymatic degradation of basement membrane collagenNature, 1980
- Collagenase in carcinoma cellsBiochemical and Biophysical Research Communications, 1972